Currently, there is a great interest in the potential medical habitudes of cannabidiol (CBD), a nenni-intoxicating cannabinoid. Créatrice pharmacological research on CBD occurred in the 1970s and intensified recently with many discoveries about the endocannabinoid system. Bigarré preclinical and clinical studies led to FDA-approval of Epidio-lex�